In esophageal squamous cell carcinoma, methylseleninic acid activated KEAP1/NRF2 pathway via upregulating miR-200a, the latter inhibited KEAP1 expression and induced expression of NRF296. This evidence concerns the gene KEAP1 and esophageal squamous cell carcinoma.